Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Locations section updated with new sites across the US (Florida, Kansas, New York), Australia (Queensland, Victoria, Western Australia), Italy (Campania, Emilia-Romagna, Friuli Venezia Giulia, Veneto), Russia (Krasnodarskiy Kray, Moscow Oblast), Ukraine (Kharkiv Governorate, Kiev Governorate, Podolia Governorate), and other regions; several previously listed locations were removed.
    Difference
    0.9%
    Check dated 2025-12-19T12:14:25.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page; this is a minor metadata change that does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T01:31:59.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1; no changes to study content, eligibility criteria, or results were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-20T22:35:54.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Taiwan trial site entries were renamed from 'Tainan City, Taiwan, 00704' and 'Tainan City, Taiwan, 710' to 'Tainan, Taiwan, 00704' and 'Tainan, Taiwan, 710'.
    Difference
    0.2%
    Check dated 2025-11-13T16:59:14.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    No substantive additions or deletions were observed; the Study Details page content and layout appear unchanged (title, study details, eligibility criteria, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:21:42.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    - The page has updated dates and a new note that the study now includes 165 locations (previously 166). - The page now shows an estimated last update date (Last Update Posted (Estimated)) for 2025-10, and an entry for 2025-10-09. - Several specific location-related entries were removed, including reference to Saint Petersburg/Sankt-Peterburg, Russia (institution name) and an entry titled Sankt-Peterburg Locations, as well as the prior date 2025-07-14 and a generic 2025-07 timestamp. - The explicit note that the study had 166 locations was deleted and replaced with 165 locations, indicating a change in scope or count. - Overall, the changes indicate a reduction in listed locations and an updated timestamp/summary for the current state, rather than a major alteration of core content.
    Difference
    1.0%
    Check dated 2025-10-16T06:11:25.000Z thumbnail image

Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.